The rationale for combining GLP-1 receptor agonists with basal insulin. [electronic resource]
Producer: 20131119Description: 246-9 p. digitalISSN:- 1326-5377
- Blood Glucose -- drug effects
- Diabetes Mellitus, Type 2 -- drug therapy
- Drug Administration Schedule
- Drug Therapy, Combination
- Evidence-Based Medicine
- Glucagon-Like Peptide 1 -- administration & dosage
- Humans
- Hypoglycemic Agents -- therapeutic use
- Insulin, Long-Acting -- administration & dosage
- Precision Medicine -- methods
- Randomized Controlled Trials as Topic
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.